Go to navigation Go to content
Phone: 515-222-1110
Lombardi Law Firm

Criminal Charges Pending against DePuy International


Blog Category:
5/29/2014
Comments (0)

Johnson & Johnson's subsidiary, DePuy, continues to receive setbacks as more lawsuits are waged with regard to the defective hip implant devices. The DePuy ASR hip implant, sold by DePuy International, was produced in India and disbursed to 100,000 patients worldwide.  While Johnson & Johnson issued recalls in Europe, the U.S. and Australia, they failed to do so in India.  Officials asked for the company to issue a recall in India too, but over one year later, nothing had been done to recall devices that were available for distribution within India.  Officials in India have thus sought relief through the criminal system, filing a police report against DePuy.  If successful, the parties involved in the failure to recall the defective devices will be sentenced to a minimum of 10 years imprisonment.  The charges are so serious because it has been nearly 4 years since the discovery that the hip implant was dangerous, and yet defective devices are still availble for implanting into patients in India, putting their health at serious risk.  In December 2013, India's regulator of medical devices, CDSCO, issued its own recall of the defective DePuy devices.  However, Johnson & Johnson itself has continued to refuse to issue a recall, despite assurances that they would do so many years ago.  Attempts by Johnson & Johnson to halt police investigations into their operations were unsuccessful, as India's High Court acknowledged the severity of the risk to patients who may receive a defective device and the need to prevent any further distribution of the device.



Category: General


There are no comments.

Post a comment

Post a Comment to "DePuy Hip Implant Recall Sparks Criminal Charges"

To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."

Name:*

Email:* (will not be published)

Message:*

Notify me of follow-up comments via email.